Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

Share this content:
Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer
 
Sponsors and Collaborators
Spectrum Pharmaceuticals, Inc.
Allergan
 
Contact
Show-Li Sun, MD
949-743-9267
show-li.sun@sppirx.com

Principal Investigator
Randil Clark, MD
North Idaho Urology
 
ClinicalTrials.gov Identifier
NCT01410565

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.